Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.93
-0.06 (-0.75%)
Jan 16, 2026, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $531.12 million as of January 16, 2026. Its market cap has decreased by -22.62% in one year.
Market Cap
531.12M
Enterprise Value
830.13M
1-Year Change
-22.62%
Ranking
Category
Stock Price
$7.93
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $531.12M, a decrease of -25.56%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 531.12M | 6.59% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |